Amgen

Amgen's stock rises after company outlines capital allocation plans
Marketwatch
Tue, 10/28/14 - 10:30 am
Amgen
Four Biotechs Lead Health Care Stocks In Big Cap 20
Investors.com
Tue, 10/28/14 - 08:44 am
Alexion
Amgen
Celgene
Regeneron
Amgen profit tops Wall Street expectations; raises 2014 outlook
Yahoo/Reuters
Mon, 10/27/14 - 05:46 pm
Amgen
earnings
Amgen Q3 Earnings Preview
Bidness Etc.
Mon, 10/27/14 - 08:19 am
Amgen
earnings
Third Point wants Amgen to explore separation
Marketwatch
Tue, 10/21/14 - 04:40 pm
Amgen
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement
Yahoo
Fri, 10/17/14 - 09:56 am
Amgen
Sanofi
Regeneron
patents
alirocumab
monoclonal antibodies
evolocumab
Can Amgen's marketing muscle vault its Humira biosim ahead of rivals?
Fierce Pharma Marketing
Wed, 10/15/14 - 11:13 am
Amgen
biosimilars
Humira
ABP 501
Novartis
Boehringer Ingelheim
Amgen spin-out on deck for IPO
Seeking Alpha
Fri, 10/10/14 - 11:42 am
Amgen
spinoffs
IPOs
Atara
Amgen, Inc. Gives AbbVie Inc the Highest Form of Flattery
Motley Fool
Fri, 10/10/14 - 10:28 am
Amgen
AbbVie
Humira
biosimilars
Amgen eyes a speedy approval for its leukemia contender
Fierce Biotech
Fri, 10/10/14 - 08:56 am
Amgen
acute lymphoblastic leukemia
blinatumomab
Phase 3 successful for Amgen's adalimumab biosimilar
Seeking Alpha
Wed, 10/8/14 - 10:09 am
Amgen
adalimumab
biosimilars
Humira
ABP 501
What Are The Best Bets In Biotech?
Investopedia
Sun, 10/5/14 - 09:58 am
Amgen
Gilead
Amgen One Step Closer To Immunotherapy Market
Bidness Etc.
Tue, 09/23/14 - 07:33 am
Amgen
immunotherapy
blinatumomab
acute lymphoblastic leukemia
UCB-Amgen Reveals Positive Data on Romosozumab for PMO
Yahoo/Zacks.com
Thu, 09/18/14 - 09:17 am
Amgen
UCB Pharmaceuticals
romosozumab
low bone mineral density
Amgen Presents Analyses Of Phase 3 Ivabradine Data For The Treatment Of Chronic Heart Failure
Yahoo
Mon, 09/15/14 - 09:21 am
Amgen
ivabradine
chronic heart failure
Five Reason Amgen Won’t Be Breaking Up
Barron's
Mon, 09/8/14 - 08:14 pm
Amgen
Amgen submits melanoma-fighter T-Vec to EMA on the heels of its FDA filing
Fierce Vaccines
Tue, 09/2/14 - 06:54 pm
T-Vex
Amgen
melanoma
FDA
Europe
vaccines
SIGNIFY Trial Provokes Sound And Fury Over Controversial Servier and Amgen Drug
Forbes
Mon, 09/1/14 - 09:50 am
clinical trials
Amgen
SIGNIFY
Servier
Procoralan
Corlentor
Amgen: Why Its New Drug Application is a Big Deal
Barron's
Thu, 08/28/14 - 07:23 pm
Amgen
evolocumab
PCSK9 inhibitors
Amgen submits U.S. application to sell cholesterol-fighting drug
Yahoo/Reuters
Thu, 08/28/14 - 10:28 am
Amgen
PCSK9 inhibitors
evolocumab

Pages